Table A7.

Tamoxifen Plus Triptorelin: Patients With Treatment Nonadherence (n = 5) and Sampling Time From Last Triptorelin Injection

Patient ID	Visit Time Point, Months	Blood Draw, Months	Blood Sample Since Last Injection, Days	E2 (pg/mL)	Duration of Tamoxifen, Months	Duration of Triptorelin, Months
B1	3	3	26	37.7	11.4	2.8
B2	3	3	29	1.21	10.6	11.5
	6	6	35	2.03	10.6	11.5
	9				10.6	11.5
	12	12	47	1.57	10.6	11.5
B3	3	3	10	6.78	10.1	11.2
	6	6	19	6.33	10.1	11.2
	9				10.1	11.2
	12	12			10.1	11.2
B4	3	3	6	2.68	4	12
	6	6	13	2.92	4	12
	9				4	12
	12	12*	108*	0.625*	4	12
B5	3	3 (ED)		5.35	3	1

Abbreviations: E2, estradiol; ED, early discontinuation

^*The patient was on aromatase inhibitor plus triptorelin at this blood draw; there is uncertainty about the value of 108 days since last injection.